Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.

Autor: Scannell RT; UCB Research, Inc., 840 Memorial Drive, Cambridge, MA 02139, USA. ralph.scannell@ucb-group.com, Arrington MP, Bayless L, Cai X, Eckman JB, Eckert M, Ene DG, Ellis JL, Hussoin S, Latham GM, Lewis TA, Libertine L, Nicolas J, Selig WM, Schwartz CE, Wels BF, Wypij DM, Young MA, Zou D

Publikováno v: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2004 Mar; Vol. 53 Suppl 1, pp. S33-4. Date of Electronic Publication: 2004 Mar 05.